{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:17:51Z","timestamp":1774027071401,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1053\/ajkd.2003.50093","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T21:29:29Z","timestamp":1206048569000},"page":"S89-S95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"S","title":["Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus"],"prefix":"10.1053","volume":"41","author":[{"given":"Mohamed E.","family":"Suliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"B\u00e1r\u00e1ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Heimb\u00fcrger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Anderstam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2003.50093_bib1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1523-1755.1998.00812.x","article-title":"Factors predicting malnutrition in hemodialysis patients: A cross-sectional study","volume":"53","author":"Qureshi","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1681\/ASN.V72198","article-title":"Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes","volume":"7","author":"Canada-USA CANUSA Peritoneal Dialysis Study Group","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 1","key":"10.1053\/ajkd.2003.50093_bib4","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1681\/ASN.V13suppl_1s28","article-title":"Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients","volume":"13","author":"Qureshi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50093_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","article-title":"The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis","volume":"329","author":"Owen","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2003.50093_bib6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1681\/ASN.V651329","article-title":"Nutrition and mortality in hemodialysis","volume":"6","author":"Bergstr\u00f6m","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50093_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(98)70148-9","article-title":"Malnutrition, cardiac disease and mortality: An integrated point of view","volume":"32","author":"Bergstr\u00f6m","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50093_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0140-6736(67)92006-5","article-title":"Cardiac failure in kwashiorkor","volume":"2","author":"Wharton","year":"1967","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2003.50093_bib9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/15.7.953","article-title":"Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)","volume":"15","author":"Stenvinkel","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50093_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","article-title":"Homocysteine and cardiovascular disease: Cause or effect?","volume":"72","author":"Brattstr\u00f6m","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/ajkd.2003.50093_bib11","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1046\/j.1523-1755.2001.59780234.x","article-title":"Homocysteine metabolism in renal failure","volume":"78","author":"van Guldener","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/ajkd.2003.50093_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1997.298","article-title":"Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology and potential relationship to arteriosclerotic outcomes","volume":"52","author":"Bostom","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/ajkd.2002.34887","article-title":"Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy","volume":"40","author":"Suliman","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50093_bib14","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1046\/j.1523-1755.2000.00018.x","article-title":"Hyperhomocysteinemia, nutritional status and cardiovascular disease in hemodialysis patients","volume":"57","author":"Suliman","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib15","first-page":"282","article-title":"Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy","volume":"18","author":"van Guldener","year":"1998","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2003.50093_bib16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ki.1993.185","article-title":"Water soluble vitamins in chronic hemodialysis and need for supplementation","volume":"43","author":"Descombes","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib17","first-page":"834","article-title":"Inhibition of the membrane transport of folates by anions retained in uremia","volume":"86","author":"Jennette","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1053\/ajkd.2003.50093_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0955-2863(94)90031-0","article-title":"Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysis","volume":"5","author":"Livant","year":"1994","journal-title":"J Nutr Biochem"},{"issue":"suppl 1","key":"10.1053\/ajkd.2003.50093_bib19","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1053\/ajkd.2001.27412","article-title":"Treatment of hyperhomocysteinemia in end-stage renal disease","volume":"38","author":"Shemin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50093_bib20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.1997.362","article-title":"Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients","volume":"52","author":"F\u00f6dinger","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib21","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1046\/j.1523-1755.1998.00918.x","article-title":"Major determinants of hyperhomocysteinemia in peritoneal dialysis patients","volume":"53","author":"Vychytil","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1515\/CCLM.2001.122","article-title":"Hyperhomocysteinemia in chronic renal failure patients: Relation to nutritional status and cardiovascular disease","volume":"39","author":"Suliman","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/ajkd.2003.50093_bib23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1523-1755.1999.00624.x","article-title":"Homocysteine and methionine metabolism in ESRD: A stable isotope study","volume":"56","author":"van Guldener","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ndt\/16.1.102","article-title":"Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients","volume":"16","author":"Suliman","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50093_bib25","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/ndt\/12.11.2332","article-title":"Total, free, and protein-bound sulphur amino acids in uraemic patients","volume":"12","author":"Suliman","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50093_bib26","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI113000","article-title":"Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation","volume":"79","author":"Moshage","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2003.50093_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0272-6386(97)90117-7","article-title":"Determinants of albumin concentration in hemodialysis patients","volume":"29","author":"Kaysen","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50093_bib28","first-page":"760A","article-title":"Relationship between changes in plasma total homocysteine and serum albumin following renal replacement therapy","volume":"13","author":"Suliman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50093_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ndt\/14.1.154","article-title":"The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass","volume":"14","author":"Brulez","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50093_bib30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.ASN.0000013299.11876.F6","article-title":"Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients","volume":"13","author":"Skoupy","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50093_bib31","series-title":"Hyperhomocysteinemia and inflammation in end-stage renal disease: Is there a link?","author":"Suliman","year":"2002"},{"key":"10.1053\/ajkd.2003.50093_bib32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ndt\/15.6.851","article-title":"The significance of serum homocysteine levels in diabetic patients on haemodialysis","volume":"15","author":"Oishi","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50093_bib33","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1523-1755.1999.0550031028.x","article-title":"Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus","volume":"55","author":"Wollesen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50093_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1681\/ASN.V61121","article-title":"Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients","volume":"6","author":"Bachmann","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50093_bib35","first-page":"S72","article-title":"Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients","volume":"41","author":"Chauveau","year":"1993","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/ajkd.2003.50093_bib36","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2003.50093_bib37","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1161\/01.ATV.17.11.2554","article-title":"Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study","volume":"17","author":"Bostom","year":"1997","journal-title":"Arterioscler Thromb Vas Biol"},{"key":"10.1053\/ajkd.2003.50093_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","article-title":"Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease","volume":"97","author":"Moustapha","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2003.50093_bib39","first-page":"170","article-title":"Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients","volume":"23","author":"Jungers","year":"1997","journal-title":"Miner Electrolyte Metab"},{"key":"10.1053\/ajkd.2003.50093_bib40","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/ndt\/14.8.1934","article-title":"Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: Is homocyst(e)ine the missing link?","volume":"14","author":"Kunz","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50093_bib41","first-page":"33","article-title":"Carotid artery stiffness in patients with end-stage renal disease: No effect of long-term homocysteine-lowering therapy","volume":"53","author":"van Guldener","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1053\/ajkd.2003.50093_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00041433-199812000-00004","article-title":"Recent data are not in conflict with homocysteine as a cardiovascular risk factor","volume":"9","author":"Refsum","year":"1998","journal-title":"Curr Opin Lipidol"},{"key":"10.1053\/ajkd.2003.50093_bib43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/72.2.324","article-title":"The controversy over homocysteine and cardiovascular risk","volume":"72","author":"Ueland","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/ajkd.2003.50093_bib44","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1053\/ajkd.2003.50093_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1389200024605091","article-title":"Hyperhomocysteinemia, pteridines and oxidative stress","volume":"3","author":"Widner","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1053\/ajkd.2003.50093_bib46","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1046\/j.1523-1755.1999.00437.x","article-title":"Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients","volume":"55","author":"Vychytil","year":"1999","journal-title":"Kidney Int"},{"issue":"suppl 12","key":"10.1053\/ajkd.2003.50093_bib47","first-page":"S24","article-title":"Epidemiology of cardiovascular risk factors in chronic renal disease","volume":"9","author":"Coresh","year":"1998","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603500725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638603500725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:19:43Z","timestamp":1759454383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638603500725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0272638603500725"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2003.50093","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2003.50093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}